Gene · 55768
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases. | Biology (Basel) | 2023 | 37759569 | PubTator, text mining | PubMed |
| Development of a PNGase Rc Column for Online Deglycosylation of Complex Glycoproteins during HDX-MS. | J Am Soc Mass Spectrom | 2023 | 37756257 | PubTator, text mining | PubMed |
| Fungal transglutaminase domain-containing proteins are involved in hyphal protection at the septal pore against wounding. | Mol Biol Cell | 2023 | 37756125 | PubTator, text mining | PubMed |
| Gut barrier defects, intestinal immune hyperactivation and enhanced lipid catabolism drive lethality in NGLY1-deficient Drosophila. | Nat Commun | 2023 | 37704604 | PubTator, text mining | PubMed |
| Dengue virus NS1 secretion is regulated via importin-subunit β1 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectin. | mBio | 2023 | 37702492 | PubTator, text mining | PubMed |
| VCP increases or decreases tau seeding using specific cofactors. | bioRxiv | 2023 | 37693404 | PubTator, text mining | PubMed |
| Neutralization, effector function and immune imprinting of Omicron variants. | Nature | 2023 | 37648855 | PubTator, text mining | PubMed |
| Congenital disorders of glycosylation: narration of a story through its patents. | Orphanet J Rare Dis | 2023 | 37644541 | PubTator, text mining | PubMed |
| Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations. | Int J Mol Sci | 2023 | 37629187 | PubTator, text mining | PubMed |
| Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants. | Front Plant Sci | 2023 | 37600182 | PubTator, text mining | PubMed |
| An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity. | Dis Model Mech | 2023 | 37589075 | PubTator, text mining | PubMed |
| Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. | Mol Neurodegener | 2023 | 37545006 | PubTator, text mining | PubMed |
| Brain-specific glycosylation enzyme GnT-IX maintains levels of protein tyrosine phosphatase receptor PTPRZ, thereby mediating glioma growth. | J Biol Chem | 2023 | 37543361 | PubTator, text mining | PubMed |
| Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression. | J Med Chem | 2023 | 37531576 | PubTator, text mining | PubMed |
| Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies. | MAbs | 2023 | 37497986 | PubTator, text mining | PubMed |
| Establishment of a CPER reverse genetics system for Powassan virus defines attenuating NS1 glycosylation sites and an infectious NS1-GFP11 reporter virus. | mBio | 2023 | 37489888 | PubTator, text mining | PubMed |
| In Vitro Reconstitution and Analysis of SARS-CoV-2/Host Protein-Protein Interactions. | ACS Omega | 2023 | 37483225 | PubTator, text mining | PubMed |
| Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination. | Nat Commun | 2023 | 37443074 | PubTator, text mining | PubMed |
| TSG101 Physically Interacts with Linear Ubiquitin Chain Assembly Complex (LUBAC) and Upregulates the TNFα-Induced NF-κB Activation. | Mol Cells | 2023 | 37431163 | PubTator, text mining | PubMed |
| Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion. | Front Endocrinol (Lausanne) | 2023 | 37388215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55768/papers?page=6